Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
Brigham and Women's Hospital · Harvard University
Indexed incrossrefpubmed
Abstract
Objective
To investigate whether vitamin D and marine derived long chain omega 3 fatty acids reduce autoimmune disease risk.
Design
Vitamin D and omega 3 trial (VITAL), a nationwide, randomized, double blind, placebo controlled trial with a two-by-two factorial design.
Citation impact
398
total citations
- FWCI
- 55.17
- Percentile
- 100%
- References
- 40
Citations per year
Authors
10- JHJill HahnCorresponding
Brigham and Women's Hospital, Harvard University
- NRNancy R. Cook
Brigham and Women's Hospital, Harvard University
- EKErik K. Alexander
Brigham and Women's Hospital, Harvard University
- SFSonia Friedman
Brigham and Women's Hospital
- JWJoseph Walter
Brigham and Women's Hospital, Harvard University
Topics & keywords
Topics
Keywords
- Medicine
- Hazard ratio
- Internal medicine
- Rheumatoid arthritis
- Vitamin D and neurology
- Clinical endpoint
- Placebo
- Randomized controlled trial
UN Sustainable Development Goals
- Life below water
No related works found for this paper.